These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 439006)

  • 21. Leakage of dl-propranolol from cerebrospinal fluid to the bloodstream in the rabbit.
    Anderson WP; Korner PI; Bobik A; Chalmers JP
    J Pharmacol Exp Ther; 1977 Aug; 202(2):320-5. PubMed ID: 886469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure.
    Manunta P; Rogowski AC; Hamilton BP; Hamlyn JM
    J Hypertens; 1994 May; 12(5):549-60. PubMed ID: 7930555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo study of propranolol and metabolite(s) disposition in rat liver.
    Ong H; du Souich P; Marchand C
    Drug Metab Dispos; 1981; 9(6):529-34. PubMed ID: 6120811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of week-long infusion of propranolol, via an osmotic minipump, on blood pressure, heart rate and vascular responses in spontaneously hypertensive rats.
    Sun CL; Thompson TJ; Hanig JP
    J Pharm Pharmacol; 1984 Jun; 36(6):401-3. PubMed ID: 6146674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rectal and intravenous propranolol infusion to steady state: kinetics and beta-receptor blockade.
    de Leede LG; Hug CC; de Lange S; de Boer AG; Breimer DD
    Clin Pharmacol Ther; 1984 Feb; 35(2):148-55. PubMed ID: 6319066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propranolol does not alter flutoprazepam kinetics and metabolism in the rat.
    Conti I; Sarati S; Caccia S
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):53-8. PubMed ID: 1936062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propranolol in conscious spontaneously hypertensive rats. I. Cardiovascular effects after subcutaneous and intracerebroventricular administration.
    Smits JF; van Essen H; Struyker-Boudier HA
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Oct; 309(1):13-8. PubMed ID: 522893
    [No Abstract]   [Full Text] [Related]  

  • 29. O-methylated catechol-like metabolites of propranolol in man.
    Walle T; Conradi EC; Walle UK; Gaffney TE
    Drug Metab Dispos; 1978; 6(4):481-7. PubMed ID: 28930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of chronic infusion of propranolol in the conscious spontaneously hypertensive rat.
    Smits JF; van Essen H; Struyker-Boudier HA
    J Pharm Pharmacol; 1980 Feb; 32(2):139-40. PubMed ID: 6103038
    [No Abstract]   [Full Text] [Related]  

  • 31. Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.
    Evans GH; Shand DG
    Clin Pharmacol Ther; 1973; 14(4):487-93. PubMed ID: 4723255
    [No Abstract]   [Full Text] [Related]  

  • 32. Direct measurement of propranolol bioavailability during accumulation to steady-state.
    Wood AJ; Carr K; Vestal RE; Belcher S; Wilkinson GR; Shand DG
    Br J Clin Pharmacol; 1978 Oct; 6(4):345-50. PubMed ID: 698031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug absorption and metabolism studies by use of portal vein infusion in the rat. II. Influence of dose and infusion rate on the bioavailability of propranolol.
    Suzuki T; Isozaki S; Ishida T; Saito Y; Nakagawa F
    Chem Pharm Bull (Tokyo); 1974 Jul; 22(7):1639-45. PubMed ID: 4434590
    [No Abstract]   [Full Text] [Related]  

  • 34. Accumulation kinetics of propranolol in the rat: comparison of Michaelis-Menten-mediated clearance and clearance changes consistent with the "altered enzyme hypothesis".
    Weber C; Stoeckel K; Lalka D
    Pharm Res; 1994 Mar; 11(3):420-5. PubMed ID: 8008710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous propranolol infusion following abdominal surgery.
    Smulyan H; Weinberg SE; Howanitz PJ
    JAMA; 1982 May; 247(18):2539-42. PubMed ID: 7069919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Massive propranolol metabolite retention during maintenance hemodialysis.
    Stone WJ; Walle T
    Clin Pharmacol Ther; 1980 Oct; 28(4):449-55. PubMed ID: 7408404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug absorption and metabolism studies by use of portal vein infusion in the rat. I. Pyloric vein cannulation and its application to study of first-pass effect on bioavailability of propranolol.
    Suzuki T; Saito Y; Isozaki S; Ishida R
    Chem Pharm Bull (Tokyo); 1972 Dec; 20(12):2731-5. PubMed ID: 4652825
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of feeding on the systemic clearance of indocyanine green and propranolol blood concentrations and plasma binding.
    Feely J; Nadeau J; Wood AJ
    Br J Clin Pharmacol; 1983 Mar; 15(3):383-5. PubMed ID: 6849770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The osmotic minipump: a new tool in the study of steady-state kinetics of drug distribution and metabolism.
    Struyker-Boudier HA; Smits JF
    J Pharm Pharmacol; 1978 Sep; 30(9):576-8. PubMed ID: 29098
    [No Abstract]   [Full Text] [Related]  

  • 40. Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.
    Evans GH; Shand DG
    Clin Pharmacol Ther; 1973; 14(4):494-500. PubMed ID: 4723256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.